Wealth Architects LLC Cuts Stake in Oracle Corporation $ORCL

Wealth Architects LLC lessened its holdings in shares of Oracle Corporation (NYSE:ORCL) by 7.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,419 shares of the enterprise software provider’s stock after selling 263 shares during the quarter. Wealth Architects LLC’s holdings in Oracle were worth $747,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ORCL. Nuveen LLC bought a new stake in shares of Oracle during the first quarter valued at approximately $732,692,000. Vanguard Group Inc. increased its holdings in Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after acquiring an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC purchased a new stake in Oracle in the 2nd quarter worth $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock valued at $648,572,000 after purchasing an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in shares of Oracle by 840.7% during the second quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after purchasing an additional 1,894,157 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Oracle Stock Down 1.3%

Shares of NYSE ORCL opened at $293.04 on Monday. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The firm has a 50-day simple moving average of $266.69 and a two-hundred day simple moving average of $210.74. The company has a market cap of $835.40 billion, a P/E ratio of 67.83, a PEG ratio of 3.15 and a beta of 1.53. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62.

Oracle (NYSE:ORCL) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period in the prior year, the company posted $1.39 EPS. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be paid a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Insiders Place Their Bets

In other news, insider Clayton M. Magouyrk sold 21,241 shares of the business’s stock in a transaction on Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the sale, the insider directly owned 78,000 shares of the company’s stock, valued at approximately $23,174,580. The trade was a 21.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Naomi O. Seligman sold 2,222 shares of the firm’s stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the completion of the transaction, the director directly owned 29,225 shares in the company, valued at $8,443,394.75. This represents a 7.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 104,314 shares of company stock valued at $31,272,223 in the last three months. 40.90% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Cowen reiterated a “buy” rating and issued a $375.00 target price on shares of Oracle in a research report on Wednesday, September 10th. Piper Sandler upped their price objective on Oracle from $270.00 to $330.00 and gave the stock an “overweight” rating in a report on Wednesday, September 10th. JMP Securities restated a “market outperform” rating and set a $342.00 target price on shares of Oracle in a research report on Wednesday, September 24th. Jefferies Financial Group lifted their price target on Oracle from $270.00 to $360.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, UBS Group set a $364.00 price objective on Oracle in a research report on Friday, September 26th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $306.71.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.